tiprankstipranks
TransCode Therapeutics (RNAZ)
NASDAQ:RNAZ
US Market

TransCode Therapeutics (RNAZ) Balance Sheet

211 Followers

TransCode Therapeutics Balance Sheet

TransCode Therapeutics's total assets for Q4 2023 were $7.29M, a decrease of -28.72% from the previous quarter. RNAZ total liabilities were $2.71M for the fiscal quarter, a -53.24% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Assets
$ 5.17M$ 7.59M$ 22.94M$ 1.06M$ 204.47K
Total Liabilities
$ 3.53M$ 4.35M$ 2.53M$ 4.46M$ 1.31M
Total Equity Gross Minority
$ 1.66M$ 3.21M$ 20.40M$ -3.41M$ -1.11M
Total Capitalization
$ 1.68M$ 3.24M$ 20.40M$ -1.32M$ -181.97K
Preferred Stock Equity
-----
Capital Lease Obligations
-----
Currency in USD

TransCode Therapeutics Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis